NCT06904066
- Conditions
- Blood Cancer, Blood Protein Disorders, Bone Marrow Diseases, +42 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Myelodysplastic-Myeloproliferative Diseases
Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.
385 public trials
63 recruiting studies
Myelodysplastic-Myeloproliferative Diseases trial results
NCT06566742
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +13 more
- Locations
-
- University of Miami Miami, Florida, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT07033598
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- Winship Cancer Institute at Emory Atlanta, Georgia, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT07302776
- Conditions
- Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +21 more
- Locations
-
- Stanford University Palo Alto, California, United States
NCT07143669
- Conditions
- Autonomic Nervous System Diseases, Bone Marrow Diseases, Chronic Disease, +29 more
- Locations
-
- AllerVie Clinical Research Birmingham, Alabama, United States
- O'Neal Comprehensive Cancer Center at the UAB Birmingham, Alabama, United States
- Kaiser Permanente San Diego San Diego, California, United States
- Allergy & Asthma Clinical Research of the Bay Area Walnut Creek, California, United States
Recruiting
Pacritinib in CMML
NCT06159491
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +11 more
- Locations
-
- The Mount Sinai Hospital New York, United States
NCT04708054
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Recruiting
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
NCT03383575
- Conditions
- Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +22 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Cleveland Clinic Foundation Cleveland, Ohio, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT05092451
- Conditions
- Acute Myeloid Leukemia (AML), B-cell Lymphoma, Blastic Transformation of Chronic Myeloid Leukemia, +39 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04996875
- Conditions
- Advanced Systemic Mastocytosis (AdvSM), Aggressive Systemic Mastocytosis (ASM), Bone Marrow Diseases, +35 more
- Locations
-
- University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
- Mayo Clinic Arizona Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UCLA Medical Center Los Angeles, California, United States